Dale Bredesen, MD

• bio

  Dale Bredesen, MD, is a neuroscientist who has carried out research on neurodegenerative diseases for over thirty years. Bredesen received a BS from the California Institute of Technology and an MD from Duke University Medical Center. He was chief resident in neurology at the University of California, San Francisco, where he also carried out research with the Nobel Laureate Stanley Prusiner. Bredesen was a member of the National Advisory Council on Aging of the National Institute on Aging and was the founding president and CEO of the Buck Institute for Research on Aging. He is currently on the faculty in the Department of Molecular and Medical Pharmacology at the University of California, Los Angeles. His latest book is The End of Alzheimer’s Program: The First Protocol to Enhance Cognition and Reverse Decline At Any Age. Bredesen works with Apollo Health to implement the Bredesen protocols.